A sales representative reported that on (b)(6) 2019, the c7000 cusa clarity console had a system error.1208 ib_vacuum_pressure-low.The product had a very low aspiration set at 100%; they checked contamination guard, canister and tube lining.Low suction noticed from system port and a possible system internal issue.The malfunction did not result in patient injury.The customer used a competitor product instead.
|
The device was returned for evaluation.The complaint was verified as valid.The service evaluation confirmed the customer's complaint; the cause was identified as the console's aspiration assembly elbow open orifice (part number 72904869) was broken and thus the cause of the complaint incident.The device history record showed no anomalies that could be associated with the complaint incident were observed.There was no service history for the device under evaluation.Device identifier: (b)(4).Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 and 30jun2020.Integra lifesciences contacted (b)(4), director of regulatory programs, office of product evaluation and quality and (b)(4), assistant director, mdr team, office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
|